|Bid||28.27 x 200000|
|Ask||28.54 x 200000|
|Day's range||28.25 - 28.27|
|52-week range||28.25 - 72.44|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||19 Feb 2024 - 23 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Unlock the potential of InvestingPro for up to 60% off this Cyber Monday Extended and never miss out on a market winner again.
LAKE FOREST, Calif., December 04, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment of Lilian Zhou to its Board of Directors, effective December 4, 2023.
With its stock down 18% over the past month, it is easy to disregard STAAR Surgical (NASDAQ:STAA). However, the...